A multi-disciplinary team of Vanderbilt investigators has demonstrated that liraglutide reduces the inflammatory response to RSV infection in a mouse model of the disease.
Vanderbilt University researchers, and students, have developed a number of technologies that provide needed care or services for our youngest population.
